Orexin1 Receptors The different approaches currently under investigation have varying degrees of therapeutic efficacy tuskonus May 4, 2023
Orexin1 Receptors Case 2 shows constraints and tumor BED for the case where the optimal dosing is not equal to the intersection of the MTD constraints tuskonus April 21, 2023
Orexin1 Receptors Compound stocks and shares were assembled in 96-very well V-bottom plates (Greiner) tuskonus October 6, 2021